COVID and CV Public Health Trials 2021: Promoting We vs I
Episode Description
Trials on lowering salt consumption and treating hypertension in the community impressed Drs Harrington and Gibson in this discussion of the best public health research of 2021.
This podcast is intended for healthcare professionals only.
To read a transcript or to comment, visit:
https://www.medscape.com/author/bob-harrington
CV Public Health Trials
Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS) https://doi.org/10.1016/j.ahj.2019.12.020
A Cluster Randomized Trial of a Village Doctor-Led Intervention on Blood Pressure Control: China Rural Hypertension Control Project
A Remotely Delivered Hypertension and Lipid Program in 10,000 Patients Across a Diverse Health Care Network
COVID-19 Public Health Trials
Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh
Dexamethasone in Hospitalized Patients with Covid-19
https://doi.org/10.1056/NEJMoa2021436
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19
https://jamanetwork.com/journals/jama/fullarticle/2775280
The Recovery Trial Initiative
https://www.recoverytrial.net/results
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology
Questions or feedback, please contact
news@medscape.net
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
